Global Tumor Ablation Market Worth Around $3.2 Billion By 2026: Acumen Research and Consulting

Author: Acumen Research and Consulting

The global tumor ablation market size is anticipated to around USD 3.2 billion by 2026, this market is anticipated to grow with 12.1% CAGR during the forecast time period. Rising occurrence of cancer is the main parameter driving to market development. Based on data published on the (WHO) World Health Organization, around 13.0% of the global populace hurt from cancer. Also, a 70.0% increase is anticipated in the disease occurrence during the forthcoming years.

Consequently, more than 100 cancer types need tumor ablation, thus increasing market development. Technological progressions in the field of thermal ablation technologies is expected to drive the market development. Rising geriatric populace is also probable to improvement market development.

Download Report Sample Pages For Better Understanding@ 

As per WHO, asurge in global population is anticipated from 12.0% in 2015 to 22.0% in 2050. Therefore, with growing geriatric populace, the needfor (MIS) Minimally Invasive Surgeries such as radio frequency ablation, is increasing. Wide deployment of these procedures due to their advantages, for instance, less trauma, speedy recovery, and minimal complications, is expected to improvement the need for tumor ablation technologies. Active role of healthcare agencies and government to produce consciousness about numerous types of cancer is additional anticipated to accentuate the deployment of this therapy.


Along with thermal ablation, methods, for instance,irreversible electroporation, laser ablation, and (HIFU), High Intensity Focused Ultrasound are also attaining popularity, which, in turn, is supportive the tumor ablation market. Growing per capita income, particularly in emerging regions, is also motivating the market development. Increase in disposable income levels is boosting people to undergo progressive therapy for tumors, there fore supporting market development.

The global tumor ablation market is segmented into technology, treatment, application and region. On the basis of technology, the global tumor ablation market is segmented into radio frequency, microwave, and cryoablation. On the basis of treatment,the global tumor ablation market is segmented into surgical, laparoscopic and percutaneous. On the basis of the application, the global tumor ablation market is segmented into liver cancer, breast cancer, lung cancer, prostate cancer, and other cancer. On the basis of region the global tumor ablation market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East & Africa.

North America captures the major market share in 2018 accounting for over 34.6% of its share and is projected to continue its dominance during the forthcoming. Main parameter contributing to development of this region comprise government support for high purchasing power parity, quality healthcare, availability of reimbursement, and growing occurrence of cancers in Canada and U.S.

Such as, in U.S., the (PPACA) Patient Protection and Affordable Care Act, also called as Obama Care, encourages quality and affordability of health insurance and decreases the cost of healthcare for individuals and government. Government initiatives, for instance, Precision Medicine Initiative formulating tailored tactics on unique features of diseases, are aiding in improving the overall healthcare system, there fore increasing market development.

Europe captured the market share 24.5% of the global market share during the forecast period. Greater extent of public funding in Europe’s healthcare system has backed to this development. Furthermore, occurrence of target populace base paired with government support to control cancer captures to significant development of this region. Such as, formation of bodies, for instance, the European Cancer Observatory, produced consciousness about cancer.

Asia Pacific is anticipated to observer profitable development forthcoming due to helpful government initiatives and improving healthcare infrastructure. Furthermore, economic growths in countries, for instance, China and India, are anticipated to aiddrive the market development. Enormous populace base with low per capita income in the region captures to high need for reasonable treatment options.

Multinational businesses are looking forward to capitalising in the emerging nations of Asia Pacific. Therefore, numerous integration partnerships and planned associations are taking place with businesses in this region. All these parameters is expected to spur the market development.

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. And also, growing R&D investments paired with technical advancements to commercialize highly efficient products are expected to offer huge growth opportunities for industry participants. Some of the main businesses present in the tumor ablation market are Misonix, Inc.,Covidien PLC,Boston Scientific Corporation,Angiodynamics, HealthTronics, EDAP TMS S.A.,SonaCare Medical,Galil Medical, Inc.,Medtronic Plc.,and Neuwave Medical, Inc. Significant strategic initiatives undertaken by global businesses include partnerships, new product launch, acquisitions.


The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - 

Would like to place an order or any question, please feel free to contact at